4.2 Review

Different Applications of Virus-Like Particles in Biology and Medicine: Vaccination and Delivery Systems

Journal

BIOPOLYMERS
Volume 105, Issue 3, Pages 113-132

Publisher

WILEY
DOI: 10.1002/bip.22759

Keywords

virus-like particles; prokaryotic and eukaryotic systems; vaccination; delivery system; clinical trials

Funding

  1. Iran National Science Foundation (INSF) [91060229]

Ask authors/readers for more resources

Virus-like particles (VLPs) mimic the whole construct of virus particles devoid of viral genome as used in subunit vaccine design. VLPs can elicit efficient protective immunity as direct immunogens compared to soluble antigens co-administered with adjuvants in several booster injections. Up to now, several prokaryotic and eukaryotic systems such as insect, yeast, plant, and E. coli were used to express recombinant proteins, especially for VLP production. Recent studies are also generating VLPs in plants using different transient expression vectors for edible vaccines. VLPs and viral particles have been applied for different functions such as gene therapy, vaccination, nanotechnology, and diagnostics. Herein, we describe VLP production in different systems as well as its applications in biology and medicine. (C) 2015 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available